MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2

Nature Microbiology

Volumn 1, Issue 3, 2016, Pages

  Yeung, Man Lung ^a,b   Yao, Yanfeng ^c   Jia, Lilong ^b   Chan, Jasper F W ^a,b   Chan, Kwok Hung ^b   Cheung, Kwok Fan ^b   Chen, Honglin ^a,b   Poon, Vincent K M ^b   Tsang, Alan K L ^b   To, Kelvin K W ^a,b   Yiu, Ming Kwong ^b   Teng, Jade L L ^b   Chu, Hin ^b   Zhou, Jie ^a,b   Zhang, Qing ^b   Deng, Wei ^c   Lau, Susanna K P ^a,b   Lau, Johnson Y N ^b   Woo, Patrick C Y ^a,b   Chan, Tak Mao ^b   Yung, Susan ^b   Zheng, Bo Jian ^a,b   Jin, Dong Yan ^b   Mathieson, Peter W ^b   Qin, Chuan ^c   Yuen, Kwok Yung ^a,b   more..

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CATALASE; CLUSTERIN; FIBROBLAST GROWTH FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMAD7 PROTEIN; SUPEROXIDE DISMUTASE; SMAD7 PROTEIN, HUMAN;

ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; ARTICLE; CALLITRICHINAE; CARDITIS; CELL DEATH; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ELECTRON MICROSCOPY; FATTY LIVER; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CELL; KIDNEY FAILURE; KIDNEY INFECTION; LIVER FIBROSIS; LIVER NECROSIS; LIVER REGENERATION; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NEPHRITIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION; UPREGULATION; VIRUS DETECTION; VIRUS TITRATION; ANIMAL; CALLITHRIX; CORONAVIRUS INFECTION; DISEASE MODEL; HOST PATHOGEN INTERACTION; KIDNEY; LUNG; METABOLISM; ORGAN CULTURE TECHNIQUE; PATHOGENICITY; PATHOLOGY;

ANIMALS; APOPTOSIS; CALLITHRIX; CORONAVIRUS INFECTIONS; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTOR 2; HOST-PATHOGEN INTERACTIONS; HUMANS; KIDNEY; LUNG; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; ORGAN CULTURE TECHNIQUES; SMAD7 PROTEIN;

EID: 84990026132     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/nmicrobiol.2016.4     Document Type: Article

References (30)

1. Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D., & Fouchier, R. A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814-1820 (2012).
2. Chan, J. F., et al. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin. Microbiol. Rev. 28, 465-522 (2015).
3. Arabi, Y. M., et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann. Intern. Med. 160, 389-397 (2014).
4. Chan, J. F., et al. Is the discovery of the novel human betacoronavirus 2c EMC/ 2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J. Infect. 65, 477-489 (2012).
5. Eckerle, I., Muller, M. A., Kallies, S., Gotthardt, D. N., & Drosten, C. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection. Virol. J. 10, 359 (2013).
6. Chan, J. F., et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J. Infect. Dis. 207, 1743-1752 (2013).
7. Chu, K. H., et al. Acute renal impairment in coronavirus-Associated severe acute respiratory syndrome. Kidney Int. 67, 698-705 (2005).
8. Hung, I. F., et al. Viral loads in clinical specimens and SARS manifestations. Emerg. Infect. Dis. 10, 1550-1557 (2004).
9. Poissy, J., et al. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J. Clin. Virol. 61, 275-278 (2014).
10. Drosten, C., et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect. Dis. 13, 745-751 (2013).
11. Ito, H., Bando, H., Shimada, T., & Katsuma, S. The BIR and BIR-like domains of Bombyx mori nucleopolyhedrovirus IAP2 protein are required for efficient viral propagation. Biochem. Biophys. Res. Commun. 454, 581-587 (2014).
12. Schiffer, M., et al. Apoptosis in podocytes induced by TGF-beta and Smad7. J. Clin. Invest. 108, 807-816 (2001).
13. Lan, H. Y., et al. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J. Am. Soc. Nephrol. 14, 1535-1548 (2003).
14. Okado, T., et al. Smad7 mediates transforming growth factor-beta-induced apoptosis in mesangial cells. Kidney Int. 62, 1178-1186 (2002).
15. Bitzer, M., et al. A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev. 14, 187-197 (2000).
16. Wang, J., et al. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro. J. Pathol. 230, 441-452 (2013).
17. Floege, J., et al. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J. Clin. Invest. 96, 2809-2819 (1995).
18. Li, Z., Jerebtsova, M., Liu, X. H., Tang, P., & Ray, P. E. Novel cystogenic role of basic fibroblast growth factor in developing rodent kidneys. Am. J. Physiol. Renal Physiol. 291, F289-F296 (2006).
19. Zorzi, F., et al. A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease. Aliment. Pharmacol. Ther. 36, 850-857 (2012).
20. Monteleone, G., et al. Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease. Mol. Ther. 20, 870-876 (2012).
21. Yao, Y., et al. An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. J. Infect. Dis. 209, 236-242 (2014).
22. Chan, J. F., et al. Treatment with lopinavir/ritonavir or interferon-β1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J. Infect. Dis. 212, 1904-1913 (2015).
23. Chu, H., et al. Middle east respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J. Infect. Dis. http://dx.doi.org/10.1093/infdis/jiv380 (2015).
24. Matsumoto, T., Turesson, I., Book, M., Gerwins, P., & Claesson-Welsh, L. p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis. J. Cell. Biol. 156, 149-160 (2002).
25. Chan, J. F., et al. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J. Infect. 67, 606-616 (2013).
26. Lu, L., et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nature Commun. 5, 3067 (2014).
27. Zumla, A., et al. Coronaviruses-drug discovery and therapeutic options. Nature Rev. Drug Discov. (in the press).
28. Zhou, J., et al. Active MERS-CoV replication and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J. Infect. Dis. 209, 1331-1342 (2014).
29. Chu, H., et al. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology 454-455, 197-205 (2014).
30. Ni, L., Saleem, M., & Mathieson, P. W. Podocyte culture: tricks of the trade. Nephrology (Carlton) 17, 525-531 (2012).